Therefore, this study sought to elucidate the mechanism by which TCF21 downregulation induces immunosuppression in NSCLC-associated TAMs, with the goal of uncovering potential targets for NSCLC immunotherapy. The gene discussed is TCF21; the disease is non-small cell lung carcinoma.